A carregar...
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a lethal thoracic malignancy whose incidence is still increasing worldwide. MPM is characterized by frequent inactivation of tumor-suppressor genes (TSGs), e.g., the homozygous deletion of CDKN2A/2B and various genetic alterations that inactivate BAP1, NF2, LA...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672749/ https://ncbi.nlm.nih.gov/pubmed/33240401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920971421 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|